Our previous study showed that Rpn10/PSMD4 (a 19S regulator) promotes tumor progression by regulating hypoxia-inducible factor 1alpha through the PTEN/Akt signaling pathway in HCC [9]. Here, PSMD4 is linked to hepatocellular carcinoma.